NL-OMON50177招募中4 期
Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia - The PPI Study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Women (>=18 years) with a singleton pregnancy diagnosed with PE with a
- •gestational age between >= 20 weeks and <35 weeks admitted to the obstetric
- •department who give written informed consent, will be included.
排除标准
- •- Multiple pregnancies , - Not willing to give written informed consent., -
- •Other reasons than (suspected) PE requiring hospitalization, - The use of PPI
- •at time of randomization, - Contraindications or hypersensitivity to PPI use, -
- •The use of medication affected by PPI , - Fetal death at time of inclusion, -
- •Signs of fetal distress at time of inclusion, - Expected delivery of <= 2 days
研究者
相似试验
进行中（未招募）
1 期
The effect of gastric reflux medication on biomarkers in toxemia of pregnancyAngiogenic markers in preeclampsiaEUCTR2018-000283-28-NL44
招募中
不适用
Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsiaNL-OMON22488one44
已完成
不适用
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152
已完成
不适用
The effect of proton pump inhibitor and potassium competitive acid blocker toward endothelial cells.healthy adultsJPRN-UMIN000024875Hamamatsu University School of Medicine70
未知
不适用
Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites.healthy volunteerJPRN-UMIN000025331Shimane university24